ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...

One of the most exciting developments in diabetes treatment is the use of new medications that help control blood sugar in ...

The U.S. Food and Drug Administration approved Merilog as biosimilar to Novolog for the improvement of glycemic control in adults and pediatric ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...

The FDA approved insulin-aspart-szjj (Merilog) as the first rapid-acting insulin biosimilar product to treat adults and ...

These drugs, called GLP1-RAs (short for glucagon-like peptide-1 receptor agonists), have been found to reduce hospital visits ...

The FDA has approved the first rapid-acting biosimilar insulin product for glycemic control in people with diabetes. Merilog ...

NSYNC’s Lance Bass shares his journey with type 1.5 diabetes, also known as latent autoimmune diabetes in adults (LADA). The ...

Type 1 and type 2 diabetes are both disorders in glucose metabolism. However, their clinical presentation and progression are different. It's important to differentiate between the two conditions ...

Patients with childhood and young adult cancer have an increased long-term risk for diabetes, noted as early as 10 years ...

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute for professional medical advice ...

A young patient identified by the ELSA study as having early stages of Type 1 Diabetes, has received treatment to delay the ...